Home » diabetic nephropathy

diabetic nephropathy

Feb 08, 2017

Penn Medicine Gets $3M From Pharma Consortium for Diabetic Kidney Disease Study

The study seeks to identify biomarkers that can help personalize treatment for patients by identifying signs of rapid decline in kidney function.

Oct 28, 2016

Myriad RBM Partnering With Sanofi on Protein Markers for Management of Type II Diabetes

Premium

The effort aims to identify a suite of markers that could aid in management of type II diabetes and related conditions like retinopathy and kidney damage.

Jun 10, 2015

Initial Validation Done, Proteomics International Seeks Partners on Kidney Disease Test

Premium

Named PromarkerD, the test is intended to predict risk of developing kidney disease in diabetics and diagnose patients with diabetic kidney disease.

Aug 24, 2012

Proteomics International Wins $1M Grant to Develop Protein Test for Diabetic Nephropathy

Premium

Proteomics firm Proteomics International said this week that it has received a A$1 million (US$ 1 million) grant from Commercialisation Australia – an initiative of the Australian government – to develop its protein biomarkers for diabetic nephropathy into a companion diagnostic.

Jan 24, 2012

EMD Millipore to Validate Proteomic International's Biomarkers

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – EMD Millipore and Proteomic International have signed a collaborative agreement to validate biomarkers related to diabetic nephropathy, the firms said today.

Oct 08, 2010

Proteomics International Developing Protein Biomarker-Based Diagnostic for Diabetic Nephropathy

Premium

The company presented a panel of 13 biomarkers for the disease at last month's Human Proteome Organization annual meeting and is looking for partners and funding to develop it as a commercial diagnostic.

The Scan

An RNAi Approval

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Keep It Going

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Stop It There

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

This Week in PLOS

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.